Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 5,437 Shares of Thermo Fisher Scientific Inc. $TMO

Key Points

• Commonwealth of Pennsylvania Public School Employees’ Retirement System reduced its Thermo Fisher Scientific stake by 6.2%, selling 5,437 shares and retaining 82,081 shares valued at approximately $41.2 million. Institutional investors collectively own 89.23% of the company.
• Thermo Fisher reported quarterly earnings of $6.03 per share and revenue of $11.99 billion, beating analyst estimates, while revenue increased 10.5% year over year. The company guided for fiscal 2026 earnings of $24.93–$25.33 per share.
• Analysts maintain a generally positive view, with a consensus “Moderate Buy” rating and an average price target of $619.41 versus the stock’s reported $588.17 price. The company also declared a quarterly dividend of $0.47 per share, yielding about 0.3%.

Commonwealth of Pennsylvania Public School Empls Retrmt SYS cut its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 6.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,081 shares of the medical research company's stock after selling 5,437 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS's holdings in Thermo Fisher Scientific were worth $41,152,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Legacy Wealth Managment LLC ID boosted its position in shares of Thermo Fisher Scientific by 78.6% during the 1st quarter. Legacy Wealth Managment LLC ID now owns 50 shares of the medical research company's stock valued at $25,000 after acquiring an additional 22 shares during the last quarter. Allied Private Wealth LLC bought a new stake in Thermo Fisher Scientific in the second quarter worth $26,000. High Note Wealth LLC raised its stake in Thermo Fisher Scientific by 170.6% during the fourth quarter. High Note Wealth LLC now owns 46 shares of the medical research company's stock valued at $27,000 after purchasing an additional 29 shares in the last quarter. Swiss RE Ltd. bought a new position in Thermo Fisher Scientific during the fourth quarter valued at $28,000. Finally, JPL Wealth Management LLC bought a new stake in shares of Thermo Fisher Scientific in the 3rd quarter worth about $28,000. Institutional investors own 89.23% of the company's stock.

Thermo Fisher Scientific Stock Performance

TMO stock opened at $588.17 on Friday. The firm has a market cap of $217.47 billion, a price-to-earnings ratio of 31.64, a PEG ratio of 2.39 and a beta of 0.85. Thermo Fisher Scientific Inc. has a twelve month low of $435.27 and a twelve month high of $643.99. The company has a quick ratio of 1.18, a current ratio of 1.55 and a debt-to-equity ratio of 0.74. The business's fifty day simple moving average is $529.37 and its two-hundred day simple moving average is $509.58.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its quarterly earnings results on Thursday, July 23rd. The medical research company reported $6.03 EPS for the quarter, topping analysts' consensus estimates of $5.71 by $0.32. Thermo Fisher Scientific had a net margin of 15.04% and a return on equity of 17.09%. The firm had revenue of $11.99 billion for the quarter, compared to analysts' expectations of $11.71 billion. During the same period in the prior year, the business posted $4.28 earnings per share. The business's revenue for the quarter was up 10.5% on a year-over-year basis. Thermo Fisher Scientific has set its FY 2026 guidance at 24.930-25.330 EPS. Analysts predict that Thermo Fisher Scientific Inc. will post 25.12 earnings per share for the current year.

Thermo Fisher Scientific Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Tuesday, September 15th will be given a dividend of $0.47 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.3%. Thermo Fisher Scientific's dividend payout ratio (DPR) is 10.11%.

Insider Activity

In other Thermo Fisher Scientific news, CAO Joseph R. Holmes sold 420 shares of Thermo Fisher Scientific stock in a transaction on Friday, August 7th. The stock was sold at an average price of $584.81, for a total transaction of $245,620.20. Following the completion of the sale, the chief accounting officer directly owned 2,966 shares of the company's stock, valued at $1,734,546.46. The trade was a 12.40% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Gianluca Pettiti sold 400 shares of the stock in a transaction on Monday, July 27th. The stock was sold at an average price of $565.00, for a total value of $226,000.00. Following the transaction, the chief operating officer directly owned 24,651 shares in the company, valued at $13,927,815. The trade was a 1.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 52,053 shares of company stock valued at $30,643,589. Insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Evercore set a $570.00 price target on shares of Thermo Fisher Scientific in a report on Monday, July 6th. Stifel Nicolaus set a $650.00 target price on Thermo Fisher Scientific in a report on Wednesday, August 5th. Robert W. Baird decreased their price target on Thermo Fisher Scientific from $653.00 to $639.00 and set an "outperform" rating on the stock in a report on Friday, April 24th. KeyCorp restated an "overweight" rating on shares of Thermo Fisher Scientific in a research report on Tuesday, May 26th. Finally, Jefferies Financial Group reiterated a "buy" rating and set a $630.00 price objective on shares of Thermo Fisher Scientific in a research report on Thursday, July 23rd. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat, Thermo Fisher Scientific presently has an average rating of "Moderate Buy" and a consensus target price of $619.41.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific NYSE: TMO is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source